There was a positive AGM statement from specialist hospital supplies business Maelor last week. Encouragingly, the statement referred to benefits from the integration of the big Acorus acquisition – some of which should be apparent in the half-year figures to the end of September – and the hunt for further acquisitions. Up from the 6.5p at which I tipped the shares a year ago to 12.75p now, Maelor is a firm hold.